# Guided Therapeutics signs $19.4M license agreement with Turkish partner ITEM

Guided Therapeutics signed a multiyear license agreement with Turkish distribution partner ITEM for the manufacture of patented single-patient-use Cervical Guides in Turkey. The agreement includes fees totaling $1.1 million in 2018 and expected minimum revenues of approximately $19.4 million over twelve years.

- Type: Contract
- Announced: 2018-04-02
- Where: Turkey, Türkiye
- Value: $19.4M
- Status: announced
- Capacity: 3,450,000 Cervical Guides over twelve years
- Products: Cervical Guides, LuViva Advanced Cervical Scans
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Guided Therapeutics](https://endata.com/companies/31057.md)
- [item](https://endata.com/companies/14005.md) (partner)

## Sources

- [biospace.com](https://www.biospace.com/guided-therapeutics-completes-license-agreement-with-turkish-distribution-partner-with-ministry-of-health-backing), 2018-04-02: "This watershed agreement has the potential to help redefine cervical cancer screening in the 21st century by applying brand new technology to a pervasive and largely unmet need in most countries."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.